Edward Albini
Equibles does not estimate personal net worth.
About Edward Albini
Earlier roles on record: CFO at Sutro Biopharma, Inc. (STRO) until May 15, 2025. Sutro Biopharma, Inc. reported in an 8-K filed March 13, 2025 that Edward Albini resigned as Chief Financial Officer, effective May 15, 2025.
“On March 13, 2025, the Company and Edward C. Albini, the Chief Financial Officer ("CFO") of the Company, entered into a Separation and Transition Services Agreement (the "Albini Separation and Transition Services Agreement") following the mutual agreement between the Board and Mr. Albini regarding his transition from his current position with the Company, effective as of May 15, 2025 (the "Albini Transition Date").”
Affiliation history
-
Start not stated–2025-05-15